Benjamin L Wolozin

Boston University

NIH Rank #1917
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#1,917
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 5 grants · National rank #1917.

Top grants by award amount

Benjamin L Wolozin's NIH grant portfolio, ranked by award amount.

  • 2R44AG060843-04R44
    Development of a novel Alzheimer's disease therapeutic targeting tau
    $999.7K
    award amount
  • 1U01AG082665-01A1U01
    APOE Genotype Mediated Effects on Alzheimer Disease Risk and Mechanisms
    $810.7K
    award amount
  • 5R01AG080810-02R01
    The role of N6-methyladenosine modified RNA in Alzheimer's disease
    $783.7K
    award amount
  • 5U01AG072577-04U01
    Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology
    $610K
    award amount
  • 3U01AG072577-04S1U01
    Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology
    $408.8K
    award amount

Affiliations

Institutions that have administered grants for Benjamin L Wolozin.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Boston University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1917
  6. 2024
    Entered Top 25% Nationally
    Ranked #1917
  7. 2024
    Entered Top 10% Nationally
    Ranked #1917
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions